Pamgene International B.V.
1 clinical trials · Sponsor
◉ Watch Pamgene International B.V.
| Record | Firm | Date |
|---|---|---|
| Observational Study of Patients With Advanced Melanoma (Skin Cancer) to Assess if IOpener®-Melanoma Test Can Predict Response to Immunotherapy. (NCT06784778) | Pamgene International B.V. | 2024-07-12 |
Track Pamgene International B.V. automatically
Every clearance here is in the API, with alerts when new ones post.